Objective.-Define the relative mortality risk by systolic (SBP) and diastolic blood pressure (DBP) in a relatively healthy cohort split by age and sex with adjustment for smoking status, other findings and admitted heart disease history.
are the 1979 Build and Blood Pressure Study and the 2003 Swiss Re Blood Pressure Study. 1, 2 However, that data is aging and, by necessity, excludes those insurance applicants not becoming or remaining insured.
Many general population studies have addressed blood pressure and mortality, but the more recent have tended to focus on the superiority of one metric or measurement approach (systolic, diastolic, mean arterial or pulse pressure) or focus on particular ages, ethnicity or BP trends over time rather than present a comprehensive table of mortality ratios by age, sex and blood pressure level.
Finally, the question is unsettled as to the relative mortality risk of those who achieve ''normal'' blood pressures by treatment vs those who come by them naturally, with different studies using different parameters coming to differing conclusions. 3 Fortunately, sufficient blood pressure data on insurance applicants with mortality follow-up is now available in conjunction with data on build, admitted hypertension and heart disease histories, and laboratory values to better assess the relative all-cause mortality risk for various systolic and diastolic blood pressure combinations.
METHODS
As part of the individual life insurance application process in the United States, urine and blood samples are routinely collected by an examiner and sent for testing to one of two laboratories including Clinical Reference Laboratory (CRL), with which the authors are affiliated. The samples are processed in an automated fashion, and the results are forwarded to the insurer requesting the testing. More recently, physical measurements (height, weight and BP) obtained by the examiner may be transmitted through the laboratory to the insurer with the laboratory results. On the CRL laboratory authorization form signed by the applicant, history questions are asked allowing ''yes'' or ''no'' answers, including: ''Do you have a history of heart disease?'' and ''Do you have a history of hypertension?' ' We studied 2,472,706 insurance applicants (31,033 deaths) ages 18 to 89 tested at CRL between 1993 and 2007 with height and weight measurements available (few available prior to 2001). All applicants with systolic blood pressures (SBP) between 90 and 199 and diastolic blood pressures (DBP) between 50 and 120 were included; 0.7% were outside of those limits, most of whom were younger females with SBP of 80 to 89 (a group discussed separately below). Followup for vital status was conducted by use of the September 2011 Social Security Death Master File. Match was by Social Security number, name and date of birth. Partial matches were manually reviewed; if the only disparity appeared to be probable name misspelling or transposition of dates, these applicants were included as well. The median duration of follow-up was 7 years (range 0 to 18).
Relative mortality risk was calculated by Cox regression analysis using IBM SPSS version 22. Preliminary analysis (not shown) included additional age splits as well as a split by smoking status, but none of these analyses showed consistent differences in resulting mortality ratios while generating wide confidence intervals for some bands because of low numbers of deaths. Because multiple studies had already determined that SBP was typically the strongest predictor of BP risk, we used that as the primary measure with subcategories based on DBP.
The base analyses were split by sex and age 18 to 59 and 60 to 89 with age and smoking (defined as urine cotinine .200 ng/ mL indicating use of tobacco or nicotine delivery device) also included as covariates. Additional analysis labeled ''covar5addi-tional'' included age-and sex-adjusted mortality risk scores for body mass index (BMI) and for urine protein/creatinine ratio (urine p/c) and a simple positive/negative for history of heart disease as covariates. This accounts for information that is often evaluated separately at the time of insurance underwriting or clinical evaluation. Those denying a heart disease history (66.5%) and not answering (32.6%) were combined as ''negative.'' Because BMI and urine p/c have a variable impact on relative mortality by age and sex, rather than use the values, the independent excess mortality risk (score) associated with those values (taken from previous research by the authors) was included as a covariate instead. 4, 5 Tables 1 to 6) . Tables 2 to 5 show the distribution by vital status and the relative mortality with 95% confidence intervals for each of the 4 age-sex combinations for bands of SBP from 90 to 199 and DBP from 50 to 120. The reference group across Tables 2 to 5 is a SBP of 120 to 124 with DBP of 70 to 79. Diastolic bands of 50 to 59 and 60 to 69 were combined for SBP bands 140+ in Tables 2 to 5 to provide narrower 95% confidence intervals. For those cells with ,5 deaths (eg, lowest diastolic band), the mortality ratio is not shown (''n/a'').
In addition to the results shown, relative mortality in the excluded SBP 80 to 89 band (combining all diastolic values) was examined relative to the same reference band as above. Meaningful results were available only for females age 18 to 59 where the MR using smoking and age covariates was 0.76 and with the additional covariates was 0.80 (data not shown), which were identical to results for the SBP 90 to 119 band.
Relative risk increased as SBP increased, but most diastolic values within each systolic category had similar mortality risk except for the lowest diastolic values (highest pulse pressure) where risk was usually substantially greater. The relationship of mortality risk associated with pulse pressure (SBP minus DBP) is explored in Figure 1 as a percentage of SBP rather than as an absolute value. Mortality ratios were generated for groups split by age 60 and by SBP 130 with age, sex, smoking and risk associated with BMI, urine p/c and heart disease history included as covariates. For subjects in pulse pressure bands #K SBP, relative mortality was very similar but for the 1% of applicants .K SBP, risk increased steeply. Table 6 is a comparison of the relative risk between those who admitted and those who denied a history of hypertension (excluding the 32.6% not answering the question). To ensure narrow 95% confidence intervals, age and sex were included as covariates rather than splitting the analysis. Additionally, DBP was only split into ,90 and $90 bands. In an adjusted analysis (including age, sex, smoking, BMI, urine p/c and heart disease history), a hypertension history increased the risk for SBP ,130 by <25%, for SBP 130 to 139 by <10%, and for SBP .139 only minimally when compared to those who selfreported no hypertension. The same analysis (data not shown) limited to age 50+ had almost identical results. 6 Our mean SBP of 117 was lower, suggesting self-selection or better blood pressure control for insurance applicants. The prevalence of hypertension (defined as treatment or BP .140/90) in the general population is stable, but the percentage of those with BP control is increasing. 7 This might be expected to result in lower mean SBP values for both the more recent general and insurance applicant populations.
DISCUSSION
In Tables 2 to 5 , there is a modest but consistent 5% to 10% reduction in the mortality ratios associated with SBP level after also accounting for BMI, urine p/c and admitted heart disease history in addition to age and smoking. A roughly similar further reduction was observed when the mortality risk associated with all of the laboratory studies was added as a covariate (not shown). n/a n/a n/a n/a n/a n/a 120 to 165 1 n/a n/a n/a n/a n/a n/a 60 to 69 3,876 34 n/a n/a n/a n/a n/a n/a 60 to 69 2,084 41 n/a n/a n/a n/a n/a n/ n/a n/a n/a n/a n/a n/a 70 to n/a n/a n/a n/a n/a n/a 60 to 69 8 238 2 n/a n/a n/a n/a n/a n/a 60 to 69 5,222 106 121 2 n/a n/a n/a n/a n/a n/ n/a n/a n/a n/a n/a n/a 70 to 14 0 n/a n/a n/a n/a n/a n/a 120 to n/a n/a n/a n/a n/a n/ n/a n/a n/a n/a n/a n/ n/a n/a n/a n/a n/a n/a 120 to n/a 5 Number of deaths ,5
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The lowest risk groups across all age and sex were those with SBP 90 to 119 (extending to SBP 80 for females age 18 to 59) consistent with many other studies showing a continuous relationship of SBP and risk with the lowest band having the lowest risk. Comparing SBP 90-119 to SBP 125-129, relative mortality increased by 13% to 32% depending on age and sex.
Within each SBP band, those with DBP ranging from 60 to 89 had similar risk which was often much lower than that for DBP 50 to 59 but only slightly lower than that for DBP 90 to 120. Very low diastolic values appeared to have higher risk related to increased pulse pressure presumably caused by a very stiff vasculature. However, rather than risk increasing progressively as pulse pressure increased, it increased only if the pulse pressure exceeded approximately K of SBP (1% of applicants) as shown in Figure 1 . This finding is consistent with data from Domanski et al (cardiovascular deaths) using the MRFIT data set and from Franklin et al (cardiovascular events) using Framingham data. 8, 9 The more limited numbers in those studies did not allow the divisions possible for our study, which more clearly shows the relatively sharp threshold at .K SBP across age and SBP. Those two studies and Sesso et al, using Physicians Health Study data, also only examined pulse pressure as an absolute value. 10 Increasing risk is also apparent for pulse pressure .K SBP in the 2003 Swiss Re study (all-cause mortality and insured lives) but only for SBP .140. 2 We were unable to find prior studies analyzing pulse pressure as a percent of SBP rather than as an absolute value.
Our finding of an increased risk for allcause mortality associated with a hypertension history when BP is controlled (Table 6) is at odds with that of Barengo et al in a 2013 Finnish population study (which also used BP of 140/90 as the discriminator for BP control and used an adjusted analysis). 5 However, cardiovascular mortality in their hypertensive history group was increased to 1.18, meaning non-cardiovascular relative mortality (not discussed in that article) for treated and controlled hypertension must have been substantially reduced for unknown reasons. That paper also reviewed prior literature (all of which was over 10 years old and much of which 1,068 4 164 0 n/a n/a n/a n/a n/a n/a 120- uses a higher BP cut-off value to define control), and found inconsistent answers on this question. Our results, showing increased risk associated with hypertension history, are based on far larger numbers but use a more selected (insurance applicant) population. Limitations for our study include dependence on 1 to 3 BP measurements (just 1 for 24% of applicants) done at a single exam by paramedical examiners whose business is, in part, dependent on insurance agent/broker satisfaction, a relationship which might be associated with downward rounding. In addition, our historical information was limited to the questions on the laboratory authorization (answer encouraged but usually not required) rather than on the insurance application. Our study population of individual life insurance applicants also has fewer serious medical conditions and a higher socio-economic status as compared to a general population sample.
CONCLUSION
Systolic blood pressure was associated with substantial increases in relative mortality across age and sex in continuous manner from SBP ,120 upward to SBP 160+ with little contribution to risk assessment by DBP. Adjustment for the impact of BMI, proteinuria and heart disease history attenuated that increase modestly. In addition, pulse pressure exceeding K SBP had substantial increased mortality.
Hypertension history with current BP control was associated with increased risk relative to those with comparable SBP but without such history.
